5Α-DIHYDROTESTOSTERONE Treatment Induces Metabolic Changes Associated with Polycystic Ovary Syndrome Without Interfering with Hypothalamic Leptin and Glucocorticoid Signaling
5Α-DIHYDROTESTOSTERONE Treatment Induces Metabolic Changes Associated with Polycystic Ovary Syndrome Without Interfering with Hypothalamic Leptin and Glucocorticoid Signaling